These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

590 related items for PubMed ID: 8756376

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Comparison of serum prostate specific membrane antigen, prostate specific antigen, and free prostate specific antigen levels in radical prostatectomy patients.
    Douglas TH, Morgan TO, McLeod DG, Moul JW, Murphy GP, Barren R, Sesterhenn IA, Mostofi FK.
    Cancer; 1997 Jul 01; 80(1):107-14. PubMed ID: 9210715
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Measurement of serum prostate-specific membrane antigen, a new prognostic marker for prostate cancer.
    Murphy GP, Kenny GM, Ragde H, Wolfert RL, Boynton AL, Holmes EH, Misrock SL, Bartsch G, Klocker H, Pointner J, Reissigl A, McLeod DG, Douglas T, Morgan T, Gilbaugh J.
    Urology; 1998 May 01; 51(5A Suppl):89-97. PubMed ID: 9610563
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Prostate cancer screening in Tyrol, Austria: experience and results.
    Horninger W, Reissigl A, Rogatsch H, Volgger H, Studen M, Klocker H, Bartsch G.
    Eur Urol; 1999 May 01; 35(5-6):523-38. PubMed ID: 10325519
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. PSA-PSMA profiles and their impact on sera PSA levels and angiogenic activity in hyperplasia and human prostate cancer.
    Ben Jemaa A, Bouraoui Y, Sallami S, Banasr A, Nouira Y, Oueslati R.
    Pathol Biol (Paris); 2014 Jun 01; 62(3):129-36. PubMed ID: 24745345
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Quantitative RT-PCR analysis of PSA and prostate-specific membrane antigen mRNA to detect circulating tumor cells improves recurrence-free survival nomogram prediction after radical prostatectomy.
    Yates DR, Rouprêt M, Drouin SJ, Comperat E, Ricci S, Lacave R, Sèbe P, Cancel-Tassin G, Bitker MO, Cussenot O.
    Prostate; 2012 Sep 01; 72(12):1382-8. PubMed ID: 22228175
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prostate carcinoma screening in the county of Tyrol, Austria: experience and results.
    Reissigl A, Horninger W, Fink K, Klocker H, Bartsch G.
    Cancer; 1997 Nov 01; 80(9):1818-29. PubMed ID: 9351555
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Impact of Circulating Tumor Cell-Expressed Prostate-Specific Membrane Antigen and Prostate-Specific Antigen Transcripts in Different Stages of Prostate Cancer.
    Cho H, Byun SS, Son NH, Chung JI, Seo WI, Lee CH, Morgan TM, Han KH, Chung JS.
    Clin Cancer Res; 2024 May 01; 30(9):1788-1800. PubMed ID: 38587547
    [Abstract] [Full Text] [Related]

  • 20. Comparison of prostate specific antigen with prostate specific antigen density for 3 clinical applications.
    Shinohara K, Wolf JS, Narayan P, Carroll PR.
    J Urol; 1994 Jul 01; 152(1):120-3. PubMed ID: 7515447
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.